Valuation: Procter & Gamble Health Limited

Market Cap 113B 1.17B 1.02B 945M 871M 1.64B 1.68B 11.29B 4.44B 55.26B 4.4B 4.3B 190B P/E 2026
24.4x
P/E 2027 * 29.5x
Enterprise Value 113B 1.17B 1.02B 945M 871M 1.64B 1.68B 11.29B 4.44B 55.26B 4.4B 4.3B 190B EV / Sales 2026
5.66x
EV / Sales 2027 * 7.06x
Free-Float
47.81%
Yield 2026 *
-
Yield 2027 * 1.74%
1 day-0.76%
1 week-0.50%
Current month+7.42%
1 month+8.40%
3 months+35.38%
6 months+24.93%
Current year+19.24%
1 week 6,740
Extreme 6740
6,955
1 month 6,190.85
Extreme 6190.85
6,955
Current year 4,699.7
Extreme 4699.7
6,955
1 year 4,699.7
Extreme 4699.7
6,955
3 years 4,640.3
Extreme 4640.3
6,955
5 years 3,883
Extreme 3883
6,955
10 years 681
Extreme 681
7,499.95
Manager TitleAgeSince
Chief Executive Officer 57 2018-03-31
Director of Finance/CFO - 2025-09-30
Chief Tech/Sci/R&D Officer - 2025-08-31
Director TitleAgeSince
Director/Board Member 57 2018-03-31
Director/Board Member 51 2019-05-31
Chairman 69 2025-03-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.76%-0.50%+15.78%+31.44% 1.17B
-0.90%-0.15%+14.11%+78.64% 48.15B
-0.23%-1.65%+67.15%+109.36% 35.59B
-0.76%-1.44%-4.29%+36.97% 11.9B
-0.88%-0.62%+17.31%+88.26% 11.85B
+0.19%+2.87%+34.92%+137.61% 9.31B
+3.37%-0.10%+51.64%-4.77% 7.02B
-0.75%-0.91%+17.45%+36.14% 6.91B
-2.25%-2.08%+0.45%+210.44% 6.55B
-9.93%+0.35%-31.51%+17.21% 6.13B
Average -1.29%+0.01%+18.30%+74.13% 14.46B
Weighted average by Cap. -0.88%-0.42%+26.70%+84.26%

Financials

2026 2027 *
Net sales 13.52B 140M 123M 113M 104M 197M 201M 1.35B 532M 6.62B 527M 516M 22.79B 15.99B 166M 145M 134M 123M 233M 238M 1.6B 630M 7.83B 624M 610M 26.96B
Net income 3.15B 32.68M 28.56M 26.35M 24.29M 45.78M 46.8M 315M 124M 1.54B 123M 120M 5.31B 3.83B 39.77M 34.75M 32.07M 29.56M 55.71M 56.95M 383M 151M 1.88B 149M 146M 6.46B
Net Debt - -
Logo Procter & Gamble Health Limited
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Employees
1,326
Date Price Change Volume
26-07-17 ₹6,797.90 -0.76% 158
26-07-16 ₹6,850.00 -0.41% 17,719
26-07-15 ₹6,877.95 -0.53% 14,343
26-07-14 ₹6,914.45 +0.73% 7,456
26-07-13 ₹6,864.30 +0.47% 863
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 500126 Stock